Print the page
Increase font size

Posted August 10, 2020

Byron King

By Byron King

A More Trustworthy Candidate

A pointed letter over the weekend, on political messages and free speech...

You have to have a screw loose to outwardly support Trump, not because Trump made promises and kept them and is a more trustworthy candidate that has stayed loyal to his promises but because the crazy people on the left are capable of being talked into anything to fight for their point, which we still don't understand.

Fringe radicalization sensationalist news media profiteering from fear and confusion

There are days worth of questions in this readers letter. Some of which have no answers in sight.

Maybe the most productive follow up question we could ask, at the risk of sounding naive: Why do we spend so much time fighting over philosophy and viewpoints

and so little time finding common ground in the quest to solve the nations problems?

Send your opinions to, TheRundownFeedback@SevenFigurePublishing.com.

Your Rundown for Monday, Aug. 10, 2020...

KODKs $765 Million On Hold

Eastman Kodak (NYSE: KODK) shares rocketed higher late last month on the July 28 news the company would pivot to manufacturing pharmaceutical components.

The U.S. International Development Finance Corp. (DFC) also pledged $765 million in loans to help KODK with the transition.

Senior administration trade advisor Peter Navarro said the loan pledge to KODK was, the beginning of American independence from our pharmaceutical dependence on foreign countries.

All good news so far.

KODK boldly enters the future with strong government support. A classic American name will have a hand in re-shoring critical pharmaceutical components.

But did someone get greedy along the way?

On Tuesday, July 21 KODK shares closed at $2.20 after roughly 117,000 shares traded hands for the day.

Fast forward to Wednesday, July 29 - the day after the news - KODK shares touched $60.00 and closed at $33.20 on volume of over 276 million shares.

Take a look

KODK

This morning, the KODK news is less rosy.

The DFC has announced the $765 million loan will not proceed until allegations of wrongdoing are cleared.

The allegations, as you might guess, surround the award of stock options granted to KODK execs in the days leading up to the announcement of the DFC loan.

Certainly, prying eyes in Congress and at the SEC will get this cleared up quickly.

Yes, we understand the absurdity of the sentence above.

But we should hope this is a nothing to see here case of inopportune timing and there was no illegality involved.

For the benefit of domestic pharmaceutical manufacturing our future depends on it.

KODK shares are down over 42% this morning, at $8.57.

Buyer beware until the smoke clears...

Market Rundown for Monday, Aug. 10, 2020

The S&Ps up 6.83 this morning at 3,358.

Oils up $0.84 at $42.06.

Gold holds above $2,000 up $27.50 at $2,055. Is the once in a generation gold bull here?

Bitcoins up at writing nearly 2%... going for $11,913 in fiat terms.

Send your comments and questions to, TheRundownFeedback@SevenFigurePublishing.com.

Well have more on Wednesday. Have a great day.

For the Rundown,

Aaron Gentzler

Aaron Gentzler

Make America Competitive Again

Make America Competitive Again

Posted June 11, 2021

The Senate passed the U.S. Innovation and Competition Act (USICA). The bill aspires to make America competitive again… and takes aim at China.
Biogen Breaks Through 5-Year Stalemate

Biogen Breaks Through 5-Year Stalemate

Posted June 09, 2021

“This could be a key moment for the biotech sector,” says our chief market analyst Greg Guenthner.
Small Business Taxed for Pandemic Shortfalls

Small Business Taxed for Pandemic Shortfalls

Posted June 07, 2021

By Aaron Gentzler

Small businesses -- hanging on by a thread -- are being taxed for pandemic shortfalls…
Trump and Biden’s “Rare” Agreement

Trump and Biden’s “Rare” Agreement

Posted June 04, 2021

By Aaron Gentzler

“Trump and Biden don’t agree on much,” says our tech expert Ray Blanco. “So what’s bringing together both sides of the aisle?”
   When It Costs Too Much…

When It Costs Too Much…

Posted June 02, 2021

By Aaron Gentzler

Over the past 15 months, pharmaceutical companies have become keenly aware of China’s dominance…
Bull Market OR Bubble?

Bull Market OR Bubble?

Posted May 28, 2021

By Aaron Gentzler

“How do you know when stocks are becoming too risky?” asks retirement specialist Zach Scheidt.